Cite

HARVARD Citation

    Elenga, N. et al. (2022). A call to start hydroxyurea by 6 months of age and before the advent of sickle cell disease complications. Pediatric blood & cancer. 69 (2), p. n/a. [Online]. 
  
Back to record